Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0105 USD | -1.87% | +7.14% | -26.06% |
Business Summary
Number of employees: 2
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Cannabinoid-based Products and Innovative Technologies
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eyal Barad
FOU | Founder | 58 | 14/09/04 |
Gabriel Yariv
CHM | Chairman | 47 | 06/10/19 |
Uri Ben-Or
DFI | Director of Finance/CFO | 52 | 04/11/16 |
- | - | ||
Ilya Reznik
PRN | Corporate Officer/Principal | - | 12/09/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eyal Barad
FOU | Founder | 58 | 14/09/04 |
Gabriel Yariv
CHM | Chairman | 47 | 06/10/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,111,352 | 31,111,352 ( 100.00 %) | 0 | 100.00 % |
Company contact information
CNBX Pharmaceuticals, Inc.
No. 3 Bethesda Metro Center Suite 700
20814, Bethesda
+877 424 2429
http://www.cnbxpharma.comSector
1st Jan change | Capi. | |
---|---|---|
-26.06% | 333K | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- CNBX Stock
- Company CNBX Pharmaceuticals Inc.